[Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes] (original) (raw)

Ugeskrift For Laeger, 2007

Abstract

Phospholipase A2 (PLA2) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.

Chen Zhan hasn't uploaded this paper.

Let Chen know you want this paper to be uploaded.

Ask for this paper to be uploaded.